Talanx Group | FY2023E | FY2024E | FY2025E |
---|---|---|---|
in EURm, IFRS17/9 | Median | Median | Median |
Insurance revenue | 42,887 | 47,171 | 49,661 |
Operating profit/loss (EBIT) | 3,573 | 4,370 | 4,680 |
Net income (attributable to Talanx shareholders) | 1,601 | 1,769 | 1,924 |
Diluted earnings per share (in EUR) | 6.25 | 6.87 | 7.42 |
Dividend per share (in EUR) | 2.30 | 2.45 | 2.75 |
Return on equity (annualised) | 17.1% | 16.7% | 15.9% |
We have included the input of all sell-side analysts in our consensus calculation who have participated in our latest survey and/or have recently published updates. By their very nature, estimates cannot be independently verified due to their subjective character. The consensus result does not imply that Talanx supports or agrees with the estimates or that it takes responsibility for the accuracy of the numbers. We have only included line items where we have received more than 2 estimates.
Disclaimer
This news release contains forward-looking statements which are based on certain assumptions, expectations and opinions of the Talanx AG management. These statements are, therefore, subject to certain known or unknown risks and uncertainties. A variety of factors, many of which are beyond Talanx AG’s control, affect Talanx AG’s business activities, business strategy, results, performance and achievements. Should one or more of these factors or risks or uncertainties materialise, actual results, performance or achievements of Talanx AG may vary materially from those expressed or implied in the relevant forward-looking statement. Talanx AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does Talanx AG accept any responsibility for the actual occurrence of the forecasted developments. Talanx AG neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.